Gilead enters $202M settlement to resolve US government's long-running HIV kickbacks probe
Authorities say Gilead paid honoraria payments, meals and travel expenses to induce participants at HIV educational speaker programs to prescribe its HIV drugs. The company is paying more than $200 million to resolve the allegations.
Authorities say Gilead paid honoraria payments, meals and travel expenses to induce participants at HIV educational speaker programs to prescribe its HIV drugs. The company is paying more than $200 million to resolve the allegations.
